CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
Amgen Inc.  (AMGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 
Prv. Close: $ 181.06 52 Wk High: $ 184.21
Week Perf: 2.02 % 52 Wk Avg: 162.67
30 Day Perf: 4.17 % 52 Wk Low: 84.77
Stock Price missing? Click here for Java troubleshoot
  AMGN Charts & Quotes
You need to upgrade your Flash Player

 Market Capitalization (Millions $) 134,165
 Shares Outstanding (Millions) 741
 Employees 17,900
 Revenues (TTM) (Millions $) 22,928
 Net Income (TTM) (Millions $) 7,893
 Cash Flow (TTM) (Millions $) 462
 Capital Exp. (TTM) (Millions $) 849
Amgen Inc.
Amgen Inc. Is a global biotechnology company that discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology. On July 15, 2002, Amgen acquired all of the outstanding common stock of Immunex Corporation (“Immunex”) for stock and cash valued at $17.8 billion in a transaction accounted for as a business combination. Immunex was a leading biotechnology company dedicated to developing immune system science to protect human health. The acquisition has enhanced Amgen’s strategic position within the biotechnology industry by strengthening and diversifying its (1) product base and product pipeline in key therapeutic areas, and (2) discovery research capabilities in proteins and antibodies.


 

Amgen's Segments
 
United States
 Segment    80.22 % of total Revenue
International
 Segment    19.78 % of total Revenue
EPOGEN TM
 Segment    17.73 % of total Revenue
Aranesp
 Segment    8.94 % of total Revenue
Prolia
 Segment    11.6 % of total Revenue
NEUPOGEN
 Segment    5.15 % of total Revenue
Nplate
 Segment    2.48 % of total Revenue
Neulasta
 Segment    42.11 % of total Revenue
XGEVA
 Segment    6.85 % of total Revenue
ENBREL
 Segment    26.45 % of total Revenue
Vectibix
 Segment    0.98 % of total Revenue
 
  Company Estimates  
  Revenue Outlook
Amgen announced annual revenue outlook on Oct. 28, 2015

Earnings Outlook
Amgen Inc. issued annual earnings guidance on Oct. 28, 2015

 
Geographic Revenue Dispersion
United States 76.74 %
International 23.26 %

Hexcel Corp

Double Digit EPS Growth, Sales Lower

Despite soft demand in the first quarter, company has managed to raise it's earnings per share, income increased by 18.64 % to $0.70 per share while Sales fell by -3.8 % to $478.80 millions, year on year.

Colgate Palmolive Co

Deterioration in Earnings, Sales Down Slightly

Colgate Palmolive Co announced disappointing results, eps deteriorated by -11.94 % to $0.59 from $0.67 and Sales declined by -0.49 % to $3.83 billions in the second quarter, year on year.


AMGN's Valuation Current
Price to Earnings PE Ratio (TTM) 17.19
Price to Earnings PE Ratio (Expected) 21.14
Price to Sales (TTM) 5.85
Price to Sales (Expected) 6.10
Price to Book 4.38
PEG (TTM) 1.5
AMGN's Financial Strength Current
Quick Ratio 3.65
Working Capital Ratio 4.41
Leverage Ratio (MRQ) 1.54
Total Debt to Equity 1.11
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.3
Per Share Current
Earnings (TTM) 10.53 $
Revenues (TTM) 30.94 $
Cash Flow (TTM) 0.62 $
Cash 51.82 $
Book Value 41.35 $
Dividend (TTM) 2.66 $

• View Valuation Comparisons • View Growth Rates Comparisons

You need to upgrade your Flash Player
AMGN's Efficiency Current
Revenue per Employee (TTM) 1,280,894
Net Income per Employee (TTM) 440,950
Receivable Turnover Ratio (TTM) 7.23
Inventory Turnover Ratio (TTM) 1.51
Asset Turnover Ratio (TTM) 0.3
AMGN's Profitability Ratio Current
Gross Margin 81.77 %
Operating Margin 47.42 %
Net Margin 37.9 %
Net Cash Flow Margin 2.14 %
Effective Tax Rate (TTM) 15.72 %
Management Effectiveness Current
Return On Assets (TTM) 10.21 %
Return On Investment (TTM) 11.87 %
Return On Equity (TTM) 26 %
Dividend Yield 1.39 %
Payout Ratio (TTM) 25.26 %
• View Efficiency Comparisons • View Profitability Comparisons • View Management Effectiveness


   
Customers Net Income fell by AMGN's customers Net margin fell to %
-4.31 % 3.68 %
   
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers
You need to upgrade your Flash Player


You need to upgrade your Flash Player

   
You need to upgrade your Flash Player
Major Competitors Stock performance

5 Days Decrease / Increase
     
ABBV        1.71% 
BIIB        0.73% 
AGN        2.5% 
JNJ        0.73% 
BMY        1.51% 
LLY        1.49% 
• View Complete Report
   



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com